
‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long - The Washington Post
The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for treating the stubbornly lethal disease.



:max_bytes(150000):strip_icc()/VWH-GettyImages-1418119350-85648874ac2e4537b2009a8bd1cbe68f.jpg)

